Arab Drug Company’s profits tick down 1% YoY in Q1 FY2023/24: Egypt

Getty Images

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector

Staff Writer, Arab Finance

November 16, 2023

PHOTO

Arab Drug Company (ADCI) reported a 1% year-on-year (YoY) slip in net profits after tax for the first quarter (Q1) of the fiscal year (FY) 2023/2024, according to the financial statement filed to the Egyptian Exchange (EGX) on November 15th.

Net profits after tax recorded EGP 27.418 million in Q1 of the current FY, down from EGP 27.695 million in Q1 of the previous FY.

Meanwhile, operating revenues grew to EGP 191.236 million from EGP 153.94 million.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.